Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2025-12-26 @ 4:55 PM
Study NCT ID:
NCT06224192
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-08
First Post:
2024-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03-15
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-17
First Submit QC Date:
None
Study First Post Date:
2024-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-06
Last Update Post Date:
2025-10-08
Last Update Post Date Type:
ESTIMATED